Plant-Derived Polyphenols in Cancer Therapy: Bridging Molecular Mechanisms and Bioavailability Toward Clinical Translation
Pharmaceutics · 13.06.2026 · 18 (6) · 737
DOI: 10.3390/pharmaceutics18060737 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 13.06.2026. Verfasst von Syed Arman Rabbani und 7 weiteren Autor:innen. Beteiligte Einrichtung: RAK College of Pharmacy, Ras Al Khaimah Medical and Health Sciences University, Ras Al Khaimah P.O. Box 11172, United Arab Emirates. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 201 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cancer is still one of the world’s major causes of morbidity and mortality; thus, safer and more efficient treatment approaches are required. The structural variety, multitargeted mechanisms, and generally good safety profiles of plant-derived polyphenols have made them attractive anticancer medicines. Flavonoids (like quercetin), stilbenes (like resveratrol), phenolic acids and curcuminoids (like curcumin) are major classes that have shown strong anticancer action against a variety of cancers, including prostate, colorectal and breast cancers. Through targets including PI3K/Akt, MAPK, NF-κB, and p53 signaling networks, these substances influence important molecular pathways involved in tumor initiation and development, including oxidative stress, inflammation, apoptosis, cell cycle control, angiogenesis and metastasis. The clinical translation of polyphenols is still constrained by poor bioavailability, fast metabolism, low aqueous solubility and inefficient pharmacokinetic characteristics, which lead to insufficient systemic exposure and therapeutic efficacy despite strong preclinical data. Their therapeutic applicability is further complicated by variations in absorption and possible dose-related restrictions. To overcome these limitations, the anticancer efficacy of polyphenols has been enhanced via delivery technologies like polymeric nanoparticles, lipid-based carriers, nanoemulsions and phytosome complexes, which have shown improved stability, increased bioavailability and targeted delivery to tumor tissues. This review provides a comprehensive and integrative analysis of plant-derived polyphenols by linking molecular mechanisms, pharmacokinetic limitations and emerging delivery strategies within a translational framework. By bridging these interconnected domains, this review highlights the potential of polyphenols as viable candidates in next-generation cancer therapeutics and underscores the need for well-designed clinical studies to facilitate their successful integration into oncology practice.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- RAK College of Pharmacy, Ras Al Khaimah Medical and Health Sciences University, Ras Al Khaimah P.O. Box 11172, United Arab Emirates.
- Amity Institute of Pharmacy, Amity University, Gurugram 122413, India.
- Department of Pharmacy, Panipat Institute of Engineering and Technology (PIET), Panipat 132102, India.
- Geeta Institute of Pharmacy, Geeta University, Panipat 132145, India.
- Department of Pharmacy, Jagannath University, Bahadurgarh 124507, India.
- Royal Cornwall Hospital Trust, NHS, Truro TR1 3LJ, UK.
ORCID-Profile: Syed Arman Rabbani, Suman Khurana, Manita Saini, Rakesh Kumar
Zitieren
APA
Rabbani, S. A., Sharma, S., El-Tanani, M., Khurana, S., Saini, M., Yadav, M., Kumar, R., & El-Tanani, Y. (2026). Plant-Derived Polyphenols in Cancer Therapy: Bridging Molecular Mechanisms and Bioavailability Toward Clinical Translation. Pharmaceutics, 18(6), 737. https://doi.org/10.3390/pharmaceutics18060737
Vancouver
Rabbani SA, Sharma S, El-Tanani M, Khurana S, Saini M, Yadav M, et al. Plant-Derived Polyphenols in Cancer Therapy: Bridging Molecular Mechanisms and Bioavailability Toward Clinical Translation. Pharmaceutics. 2026;18(6):737. doi:10.3390/pharmaceutics18060737
BibTeX
@article{Rabbani2026,
author = {Rabbani, Syed Arman and Sharma, Shrestha and El-Tanani, Mohamed and Khurana, Suman and Saini, Manita and Yadav, Monu and Kumar, Rakesh and El-Tanani, Yahia},
title = {Plant-Derived Polyphenols in Cancer Therapy: Bridging Molecular Mechanisms and Bioavailability Toward Clinical Translation},
journal = {Pharmaceutics},
year = {2026},
volume = {18},
number = {6},
pages = {737},
doi = {10.3390/pharmaceutics18060737}
}
EUVIMED